SwitzerlandCHF 84.70+2.28%
Click any ratio for an explanation.
Revenue was close to flat at +0.7% a year over the last 4 fiscal years, so growth has to come from margins rather than volume. Profit per share grew slower (-19.1% a year), so costs are eating part of the extra revenue. Analysts expect further profit growth next year: the forward multiple is +64.9% below the trailing one.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| -19.1% | -5% → +20% | 0 | 40% | |
| +0.7% | -2% → +15% | 16 | 35% | |
| +64.9% | -10% → +30% | 100 | 25% |
The share is up over every window (+7.5% in 3 months, +6.6% in 6, +10.4% in 12), a consistent uptrend. The last three months are stronger than the six-month picture, so momentum is building rather than fading.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| +7.5% | -20% → +20% | 69 | 35% | |
| +6.6% | -25% → +30% | 57 | 30% | |
| +10.4% | -30% → +45% | 54 | 35% |
Net debt of 3.45x EBITDA is heavy: a drop in earnings would quickly strain the balance sheet. Debt at 213% of equity means the balance sheet is financed mostly by lenders.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| 3.4x | 3.5x → -1.0x | 1 | 30% | |
| 213% | 200% → 10% | 0 | 20% | |
| 6.6% | 0% → 15% | 44 | 15% | |
| 0.79 | 0.8x → 2.0x | 0 | 10% | |
| 5/9 | 3/9 → 8/9 | 40 | 10% | |
| 3.1 | 1.8 → 5.0 | 40 | 10% | |
| 7.6x | 2x → 20x | 31 | 5% |
Return on equity of 26.2% means the company earns far more on its capital than it costs to fund. Roughly 8% of revenue converts into net profit, an average conversion. ROIC of 12.8% is modest, so part of the equity return comes from leverage rather than operations.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| 26.2% | 5% → 35% | 71 | 30% | |
| 16.1% | 3% → 30% | 49 | 25% | |
| 8.4% | 2% → 25% | 28 | 20% | |
| 12.8% | 4% → 20% | 55 | 15% | |
| 45.8% | 15% → 60% | 69 | 10% |
At 29.3x trailing earnings investors already pay up for future growth. The forward P/E of 17.8 is lower, so expected profit growth makes it look cheaper looking ahead. A dividend yield of 3.7% adds to the return while you wait. Based on 75% of the inputs — the rest is not published for this instrument.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| 29.3x | 40x → 8x | 33 | 30% | |
| 17.8x | 32x → 7x | 57 | 20% | |
| 16.7x | 22x → 6x | 33 | 15% | |
| 3.66% | 0% → 6% | 61 | 10% | |
| n/a | 1.6x → 0.7x | — | 25% |
Annualised volatility of 20.4% is normal for a single share. The worst fall in the past year was -8.5%, a shallow setback. A beta of 0.5 means it typically moves less than the market.
| Ratio | Value | Weak → Strong | Score | Wt |
|---|---|---|---|---|
| 20.4% | 55% → 15% | 87 | 40% | |
| -8.5% | -40% → -8% | 98 | 35% | |
| 0.5 | 1.8 → 0.7 | 100 | 25% |
Source: Yahoo Finance + EODHD
Last 5 fiscal years plus the current year. Click any row for an explanation.
Recent analyst views
Loading analyst views…
Recent analyst actions
No individual broker rating actions are published for this instrument.
- Mean target
- CHF 89.04
- Target range
- CHF 72.00 – CHF 100.00
- Implied upside
- +5.1%
- Consensus score
- 2.17
Quarterly results · 18 Feb 2027
Reports after market close
Dividend
Forward annual dividend 3.1 CHF; last ex-dividend 2026-04-20. Next date not yet published
Investor day
Checking public announcements…
Mergers & acquisitions
Checking public announcements…
Loading headlines…
Nestlé S.A., together with its subsidiaries, manufactures and distributes food and beverage, and nutritional science products in the United States, Brazil, Mexico, Greater China, the Philippines, India, the United Kingdom, France, Germany, Switzerland, and internationally. The company offers cereals, chocolate and confectionery, coffee, culinary, chilled and frozen food, dairy, drinks, food service, ice cream, nutrition and health, petcare, water, plant-based portfolio, and recipe products. It sells its products under the Nesquik Cereal, Fitness, Cheerios, Lion Cereals, Cini Minis, KitKat Cereal, Chocapic, Koko Krunch, Shreddies, Shredded Wheat Original, Corn Flakes, Trix Cereal, Aero, Baci Perugina, KitKat, Milkybar, Smarties, Cailler, Quality Street, Garoto, Nestlé Toll House, Munch, Damak, Hsu Fu Chi, Sahne Nuss, Nestlé Sustainably Sourced Cocoa, Blue Bottle Coffee, Nescafé, Nescafé Dolce Gusto, Nespresso, Starbucks Coffee At Home, DiGiorno, Garden Gourmet, Maggi, Thomy, Stouffer's, Hot Pockets, Lean Cuisine, Life Cuisine, Buitoni, Nestlé carnation, Nestlé Coffee Mate, and Nestea brands. The company also offers its products under the Roastelier by Nescafé, Plant-based and so good!, Milo, Chef, Maggi Professional, La Lechera, Minor's, Antica Gelateria Del Corso, Drumstick, Extrême, Häagen-Dazs, Maxibon, Mövenpick, Nancare, Gerber, Cerelac, Nestum, Alfaré HMO, Athéra HMO, Alfamino HMO, Bear Brand, Nido, Orgain, Nestlé Vital, Garden of Life, Pure Encapsulations, Solgar, Compleat, Impact, Peptamen, Vitaflo, Resource, Cat Chow, Dentalife, Dog Chow, Fancy Feast, Felix, Friskies, Gourmet, Purina, Purina ONE, Purina Pro Plan, Purina Pro Plan Veterinary Diets, Acqua Panna, Nestlé Pure Life, Perrier, S.Pellegrino, Sanpellegrino, Buxton, Erikli, Levissima, Vittel, Contrex, HENNIEZ, Hépar, La Vie, Naleczowianka, and Essentia brands. The company was founded in 1866 and is headquartered in Vevey, Switzerland. Aimmune Therapeutics, Inc. operates as a subsidiary of Nestlé S.A.
nestle.com